{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:27:12Z","timestamp":1772166432862,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MCT 87522"],"award-info":[{"award-number":["MCT 87522"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BC SUPPORT Unit","award":["RWCT-001"],"award-info":[{"award-number":["RWCT-001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Clinical trials commonly use multiple endpoints to measure the impact of an intervention. While this improves the comprehensiveness of outcomes, it can make trial results difficult to interpret. We examined the impact of integrating patient weights into a composite endpoint on the interpretation of Control of Hypertension in Pregnancy Study (CHIPS) Trial results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Outcome weights were extracted from a previous patient preferences study in pregnancy hypertension (\n                      <jats:italic>N<\/jats:italic>\n                      = 183 women) which identified (i) seven outcomes most important to women (taking medication, severe hypertension, pre-eclampsia, blood transfusion, Caesarean, delivery &lt; 34 weeks, and baby born smaller-than-expected) and (ii) three preference subgroups: (1) \u2018equal prioritizers\u2019, 62%; (2) \u2018early delivery avoiders\u2019, 23%; and (3) \u2018medication minimizers\u2019, 14%.\n                    <\/jats:p>\n                    <jats:p>\n                      Outcome weights from the preference subgroups were integrated with CHIPS data for the seven outcomes identified in the preference study. A weighted composite score was derived for each participant by multiplying the preference weight for each outcome by the binary outcome if it occurred. Analyses considered equal weights and those from the preference subgroups. The mean composite scores were compared between trial arms (\n                      <jats:italic>t<\/jats:italic>\n                      -tests).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Composite scores were similar between trial arms with the use of equal weights or those of subgroup (1) (95% confidence intervals [CIs]: \u2212\u20090.03, 0.02;\n                      <jats:italic>p<\/jats:italic>\n                      &gt; 0.50 for each). \u2018Tight\u2019 control was superior when using subgroup (2) weights (95% CIs: 0.002, 0.07;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.03), and \u2018less-tight\u2019 control was superior when using subgroup (3) weights (95% CIs: \u2212\u20090.11, \u2212\u20090.04;\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Evidence-based recommendations for \u2018tight\u2019 control are consistent with most women\u2019s preferences, but for a sixth of women, \u2018less-tight\u2019 control is more preference consistent. Depending on patient preferences, a single trial may support different interventions. Future trials should specify component weights to improve interpretation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov NCT01192412<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-023-07118-1","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T18:02:42Z","timestamp":1675792962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Using a patient-centred composite endpoint in a secondary analysis of the Control of Hypertension in Pregnancy Study (CHIPS) Trial"],"prefix":"10.1186","volume":"24","author":[{"given":"Rebecca K.","family":"Metcalfe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Lewisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"von Dadelszen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura A.","family":"Magee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1510-3462","authenticated-orcid":false,"given":"Nick","family":"Bansback","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the CHIPS Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,7]]},"reference":[{"key":"7118_CR1","doi-asserted-by":"publisher","first-page":"c3920","DOI":"10.1136\/bmj.c3920","volume":"341","author":"G Cordoba","year":"2010","unstructured":"Cordoba G, Schwartz L, Woloshin S, Bae H, G\u00f8tzsche PC. Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review. BMJ. 2010;341:c3920.","journal-title":"BMJ"},{"key":"7118_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jclinepi.2019.05.003","volume":"113","author":"N Panariello","year":"2019","unstructured":"Panariello N, Jurczak A, Spector J, Kumar V, Semrau K. Coherence in measurement and programming in maternal and newborn health: experience from the BetterBirth trial. J Clin Epidemiol. 2019;113:83\u20135.","journal-title":"J Clin Epidemiol"},{"key":"7118_CR3","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1161\/CIRCULATIONAHA.113.006588","volume":"130","author":"JM Stolker","year":"2014","unstructured":"Stolker JM, et al. Rethinking composite end points in clinical trials: insights from patients and trialists. Circulation. 2014;130:1254\u201361.","journal-title":"Circulation"},{"key":"7118_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1404595","volume":"372","author":"LA Magee","year":"2015","unstructured":"Magee LA, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015;372:407\u201317.","journal-title":"N Engl J Med"},{"key":"7118_CR5","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.cjca.2018.02.021","volume":"34","author":"S Butalia","year":"2018","unstructured":"Butalia S, et al. Hypertension Canada\u2019s 2018 Guidelines for the management of hypertension in pregnancy. Can J Cardiol. 2018;34:526\u201331.","journal-title":"Can J Cardiol"},{"key":"7118_CR6","volume-title":"WHO recommendations on drug treatment for non-severe hypertension in pregnancy","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. WHO recommendations on drug treatment for non-severe hypertension in pregnancy. (2020)."},{"key":"7118_CR7","volume-title":"Hypertension in pregnancy: diagnosis and management","author":"National Institute for Health and Care Excellence","year":"2019","unstructured":"National Institute for Health and Care Excellence. Hypertension in pregnancy: diagnosis and management, vol. 55 https:\/\/www.nice.org.uk\/guidance\/ng133; 2019."},{"key":"7118_CR8","doi-asserted-by":"publisher","unstructured":"Magee LA, et al. The hypertensive disorders of pregnancy: the 2021 International Society for the Study of Hypertension in Pregnancy Classification, Diagnosis & Management Recommendations for International Practice. Pregnancy Hypertens. 2021. https:\/\/doi.org\/10.1016\/j.preghy.2021.09.008.","DOI":"10.1016\/j.preghy.2021.09.008"},{"key":"7118_CR9","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa2201295","volume":"386","author":"AT Tita","year":"2022","unstructured":"Tita AT, et al. Treatment for mild chronic hypertension during pregnancy. N Engl J Med. 2022;386:1781\u201392.","journal-title":"N Engl J Med"},{"key":"7118_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/jan.13387","volume":"74","author":"M Sinclair","year":"2018","unstructured":"Sinclair M, Lagan BM, Dolk H, McCullough JEM. An assessment of pregnant women\u2019s knowledge and use of the Internet for medication safety information and purchase. J Adv Nurs. 2018;74:137\u201347.","journal-title":"J Adv Nurs"},{"key":"7118_CR11","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cjca.2020.02.090","volume":"36","author":"RK Metcalfe","year":"2020","unstructured":"Metcalfe RK, et al. Patient preferences and decisional needs when choosing a treatment approach for pregnancy hypertension: a stated preference study. Can J Cardiol. 2020;36:775\u20139.","journal-title":"Can J Cardiol"},{"key":"7118_CR12","doi-asserted-by":"publisher","unstructured":"M\u00fchlbacher AC, Zweifel P, Kaczynski A, Johnson FR. Experimental measurement of preferences in health care using best-worst scaling (BWS): theoretical and statistical issues. Health Econ Rev. 2016;6. https:\/\/doi.org\/10.1186\/s13561-015-0077-z.","DOI":"10.1186\/s13561-015-0077-z"},{"key":"7118_CR13","first-page":"1","volume-title":"Latent Gold","author":"Statistical Innovations","year":"2016","unstructured":"Statistical Innovations. Latent Gold, vol. 5; 2016. p. 1."},{"key":"7118_CR14","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ijcard.2015.05.109","volume":"195","author":"Y Ahmad","year":"2015","unstructured":"Ahmad Y, et al. A new method of applying randomised control study data to the individual patient: a novel quantitative patient-centred approach to interpreting composite end points. Int J Cardiol. 2015;195:216\u201324.","journal-title":"Int J Cardiol"},{"key":"7118_CR15","volume-title":"RStudio: integrated development for R","author":"RStudio Team","year":"2020","unstructured":"RStudio Team. RStudio: integrated development for R: (PBC; 2020."},{"key":"7118_CR16","doi-asserted-by":"publisher","unstructured":"Abalos E, Duley L, Steyn DW, Gialdini C. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2018. https:\/\/doi.org\/10.1002\/14651858.CD002252.pub4.","DOI":"10.1002\/14651858.CD002252.pub4"},{"key":"7118_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12874-019-0885-7","volume":"19","author":"UN Udogwu","year":"2019","unstructured":"Udogwu UN, et al. A patient-centered composite endpoint weighting technique for orthopaedic trauma research. BMC Med Res Methodol. 2019;19:242.","journal-title":"BMC Med Res Methodol"},{"key":"7118_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/eurheartj\/ehr352","volume":"33","author":"SJ Pocock","year":"2012","unstructured":"Pocock SJ, Ariti CA, Collier TJ, Wang D. The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities. Eur Heart J. 2012;33:176\u201382.","journal-title":"Eur Heart J"},{"key":"7118_CR19","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1002\/sim.3923","volume":"29","author":"M Buyse","year":"2010","unstructured":"Buyse M. Generalized pairwise comparisons of prioritized outcomes in the two-sample problem. Stat Med. 2010;29:3245\u201357.","journal-title":"Stat Med"},{"key":"7118_CR20","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2307\/2531158","volume":"40","author":"PC O\u2019Brien","year":"1984","unstructured":"O\u2019Brien PC. Procedures for comparing samples with multiple endpoints. Biometrics. 1984;40:1079\u201387.","journal-title":"Biometrics"},{"key":"7118_CR21","first-page":"643","volume":"3","author":"GM Felker","year":"2010","unstructured":"Felker GM, Maisel AS. A global rank end point for clinical trials in acute heart failure. Circulation. 2010;3:643\u20136.","journal-title":"Circulation"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07118-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07118-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07118-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T18:08:35Z","timestamp":1675793315000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07118-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,7]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7118"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07118-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1909786\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,7]]},"assertion":[{"value":"29 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Behavioural Research Ethics Board (H17-01194) at the University of British Columbia.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}